Form 4: HCSG COO Andrew Kush Reports Equity Transactions

Healthcare Services Group's EVP & COO, Andrew Kush, reported multiple equity transactions, including RSU exercises and tax-related dispositions, all under a pre-arranged 10b5-1 plan.

Summary

• Andrew Kush, EVP & Chief Operating Officer of Healthcare Services Group Inc. (HCSG), reported several transactions involving the company's equity securities.
• These transactions were conducted pursuant to a Rule 10b5-1 pre-arranged trading plan.
• Kush acquired a total of 17,349 shares of common stock through the exercise of Restricted Stock Units (RSUs) on January 3 and January 4, 2026, at an exercise price of $0.
• He disposed of 7,676 shares of common stock on January 5, 2026, for tax withholding purposes, also at a price of $0.
• Kush acquired 1,628 shares of Phantom Stock on December 31, 2025, at a conversion price of $19.12, as part of an Issuer contribution to the Deferred Compensation Plan.
• He also received a new grant of 20,060 Restricted Stock Units on January 5, 2026, which will vest at a rate of 20% annually starting from the first anniversary of the grant date.
• Following these transactions, Kush's direct beneficial ownership of common stock increased to 28,532 shares.
• His beneficial ownership of derivative securities includes 16,452 Phantom Stock units and 45,215 Restricted Stock Units across various vesting schedules.

Sentiment

Score: 6

Explanation: The filing reports routine executive equity transactions, including both acquisitions through RSU exercises and new grants, as well as dispositions for tax purposes. The overall sentiment is neutral to slightly positive due to the continued grant of equity compensation to a key executive, indicating ongoing alignment of interests, but the transactions are largely administrative and pre-planned.

Positives

• Acquisition of 1,628 Phantom Stock units through an Issuer contribution to a Deferred Compensation Plan, indicating continued long-term incentive alignment.
• Grant of 20,060 new Restricted Stock Units, demonstrating ongoing compensation and retention of a key executive.
• The transactions were executed under a Rule 10b5-1 plan, suggesting pre-planned activity rather than immediate market timing.

Negatives

• Disposition of 7,676 shares of common stock for tax withholding purposes, which reduces direct share ownership.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the vesting schedules of the granted Restricted Stock Units, which indicate future equity compensation.

Industry Context

This Form 4 filing details routine executive equity compensation and transaction activities for Healthcare Services Group Inc., a company operating in the healthcare support services sector. Such filings are standard for publicly traded companies and reflect typical executive incentive structures involving restricted stock and deferred compensation plans. The transactions themselves do not provide specific insights into broader industry trends but rather reflect internal compensation and tax planning.

Related Party Transactions

• Acquisition of 1,628 Phantom Stock units through an Issuer contribution under the Healthcare Services Group, Inc. Deferred Compensation Plan.
• Grant of 20,060 Restricted Stock Units by the Issuer to the Reporting Person.

Stakeholder Impact

• Shareholders: The increase in common stock ownership by a key executive, even if partially offset by tax-related dispositions, generally signals continued alignment of management and shareholder interests. The issuance of new RSUs and phantom stock dilutes existing shares slightly over time but serves as a retention and incentive mechanism for executive performance.
• Employees: The filing details executive compensation, which is part of the broader compensation structure within the company, potentially influencing employee morale and retention strategies.

Next Steps

• Continued vesting of 45,215 Restricted Stock Units according to their respective annual schedules (20% annually from grant dates of 01/04/2021, 01/04/2022, 01/03/2024, 01/03/2025, and 01/05/2026).
• Phantom Stock units (16,452) are payable in-kind following the termination of the Reporting Person's employment with the Issuer.

Key Dates

Recommendation

This Form 4 filing details routine, pre-planned executive equity transactions, primarily involving the exercise of Restricted Stock Units and subsequent tax-related dispositions, along with new equity grants. These activities are standard for executive compensation and do not indicate any material change in the company's operational or financial outlook. The transactions were executed under a 10b5-1 plan, which suggests they are not based on new, non-public information. Therefore, the filing itself does not provide a basis for a 'buy' or 'sell' recommendation, and a 'hold' stance is appropriate as it merely reports administrative changes in insider holdings.

Keywords

Healthcare Services Group, HCSG, Andrew Kush, Insider Trading, Form 4, Restricted Stock Units, Phantom Stock, Equity Compensation, Executive Compensation, 10b5-1 Plan